chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccinations administered on October 3 2007. Fever of 105 degrees with vomiting and shaking 12 hours after vaccinations. Patient was pale and moaning in my arms. Diarrhea followed 18 hours after vaccinations. Patient has loss of appetite. She is not eating full meals nor drinking full 8 ounce bottles as of today, October 7, 2007. She was taken to her new doctor. on October 4, 2007 and the emergency room on October 6, 2007 due to high fevers over 103 degrees. She had her ears checked, a catheter inserted for urine extraction, throat checked and blood checked for infections. She was diagnosed with NO infections. She was Not sick when vaccinations were administered and I am told that the vaccinations were not a source of her "reactions". I do NOT believe this. Her fevers are less than 105 degrees today October 7, 2007. However, patient still has fevers with loss of appetite. She was happy, healthy and eating perfecty before these vaccinations. The Health Department insists that patient is NOT having reactions. The emergency room doctor told my husband and I that the vaccinations is a possibility. I apologize for NOT knowing which legs the shots were administered in or the manufacturers names and lot numbers. I didn't know at the time of the vaccinations that I needed to know this information. She had a total of 5 shots and both legs were used.
Within a week after getting the vaccine I felt like I was having the flu. I didn't feel good. I  haven't been running a fever. I was very weak. I felt like I was sick with covid again. During that time I did fall and hurt my back again. This time it was really bad. My breathing got worse. I wake up in the morning with headaches. My underlying health conditions has gotten worse. I'm continuously losing weight. I used to weigh around 115 lbs, but now I am down to 93 lbs. If I eat I feel nauseas and sick. I went to the hospital on June 13th and they told me I was dehydrated. I was throwing up and having headaches. They hydrated me and gave me some medicine for my nausea. I haven't been able to take care of myself. The doctor is slowly trying to rule things out to figure out what is going on. I did finally get a Prolia shot. My lung doctor changed my medication. I have been having bad headaches and brain fog. I'm being referred to a gastrologist. My nose is very congested and stuffy.
Patient received an injection of SHINGRIX in the right arm.  Post vaccination patient felt there was a bump near the site of injection.  Patient is experiencing arm some pain, discomfort, and impaired arm movement in the right arm to this day 4/7/2021 after receiving the vaccine back in 12/28/2020.
Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 05-Apr-2022; Vaccine was expired on 01-Apr-2022 administered on 05-Apr-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 05-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 05-Apr-2022) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 05-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 05-Apr-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 05-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was expired on 01-Apr-2022 administered on 05-Apr-2022) and PRODUCT STORAGE ERROR (Vaccine was expired on 01-Apr-2022, refrigerated on 04-Apr-2022 and administered on 05-Apr-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The vial was initially stored in the refrigerator on 04-Apr-2022. The vial did not undergo any temperature excursions. It was reported that pharmacist thought that the vaccine was expired in Jun-2022, however it was expired on 01-Apr-2022.  No treatment information was reported   This case was linked to MOD-2022-551714 (Patient Link).
Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterates that because facility was unable to download the digital data logger, they would need to treat this issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the State at that time. It was reported that no adverse reactions were reported by any patients.  No treatment medication was reported.
There have been no adverse events reported by the patient. However, the vaccine was stored in the freezer upon it's arrival to our clinic site on 7/20/21 until 8/10/21 when we learned that the vaccine should have been stored in the refrigerator at temperatures between 36-46 degrees farenheit.  Therefore, the vaccine has no efficacy.
This spontaneous report was received from a Nurse Practitioner and refers to 15 year old female patient. The patient did not suffer from any illnesses at the time of the vaccination and did not have any preexisting allergies, birth defects or medical conditions. At 11:49 on 04-APR-2016, the patient was vaccinated with the first dose of GARDASIL 9 lot # L013429, expiration date 21-JUL-2017, intramuscularly in the left arm (dose not reported). The vaccine administered to the patient was improperly stored as it underwent temperature excursion for an unspecified cumulative period of time since January 2016 at 0.5 degrees Celsius. There had been no previous temperature excursion and the aforementioned one was identified due to a data logger. No adverse symptoms or reactions occurred. This is one of several reports received from the same source. Additional information is not expected as all scheduled correspondence has been received.
GI bleed; received dose 2 on 22Feb2021 10:15; received dose 2 on 22Feb2021 10:15; This is a spontaneous report from a contactable consumer. A 73-year-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 22Feb2021 10:15 at 73-year-old (Lot Number: EN6201) as single dose for covid-19 immunization; apixaban (ELIQUIS), via an unspecified route of administration from 22Feb2021 06:00 (Batch/Lot number was not reported), at unspecified dose for cerebrovascular accident prophylaxis. Facility type vaccine was hospital. Medical history included atrial fibrillation and diverticulum. No covid prior vaccination. No known allergies. The patient's concomitant medications were not reported. The patient previous received the first dose of the vaccine (lot number: EN5318) on 05Feb2021 12:00 at Left arm for covid-19 immunization. No other vaccine in four weeks. At 11:45 am (an hour and a half later) on 22Feb2021. The patient was admitted to the hospital via the Emergency room for a gastrointestinal bleed. The patient had taken the Eliquis at 6 am that morning. The patient was hospitalized for GI bleed from 22Feb2021 to 26Feb2021 for 4 days. The patient underwent lab tests and procedures which included Nasal Swab sars-cov-2 test: negative on 22Feb2021. The action taken in response to the event for apixaban was unknown. The outcome of the event GI bleed was recovered. Treatment of Kcentra Infusion and 2 units of blood transfusion received. Additional information received by Pfizer from Bristol-Myers Squibb (manufacturer control number: US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-026613), license party for apixaban also included: BMS's assessment (event GI bleed was serious).; Sender's Comments: This patient had developed gastrointestinal haemorrhage after receiving apixaban therapy. Based on the anticoagulant nature of apixaban, its role in the bleeding event is considered possible.
swelling at injection site; fever; redness at injection site; headache; muscle pain in neck and shoulder; This case was reported by a consumer via call center representative and described the occurrence of extensive swelling of vaccinated limb in a 62-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 19th June 2019, the patient received the 1st dose of Shingrix (intramuscular). In June 2019, less than a week after receiving Shingrix, the patient experienced extensive swelling of vaccinated limb, fever, injection site erythema and headache. On 20th June 2019, the patient experienced muscle pain. The patient was treated with ibuprofen. On an unknown date, the outcome of the extensive swelling of vaccinated limb and injection site erythema were not recovered/not resolved and the outcome of the fever, muscle pain and headache were recovered/resolved.   It was unknown if the reporter considered the extensive swelling of vaccinated limb, fever, injection site erythema, muscle pain and headache to be related to Shingrix.  Additional details were provided as follows: The patient had never had measles.  The patient wanted to know how long after receiving Shingrix she had to wait to get Measles Mumps Rubella shot.  The patient received Shingrix vaccine in the right deltoid muscle and it knocked her for a loop. The patient got a fever of 101 degree F and got a baseball size swelling and redness at the injection site.  On 20th June 2019, 1 day after receiving Shingrix, she woke up with muscular pain in the neck and shoulder that lasted for 3 days and was treated with ibuprofen.  The patient also experienced a headache.  The patient's right deltoid muscle and was still red and swollen but her other symptoms had resolved, at the the time of reporting. The reporter consented to follow up.
Supraclavicular node swelling and tenderness, neck and shoulder pain on side of vaccine administration; similar, but more localized to injection site, pain with first Menactra at age 15yrs.
My severe chest cold symptoms started on 01/19/2023 in the afternoon. I had a sinus congestions, sore throat, and no fever. I called and made an appointment to my doctor's office for 01/30/2023. My doctor prescribed me with AUGMENTIN for 10 days. On 01/27/2023 I did a COVID-19 home test which was negative.
Intense pain between shoulders on 4/11/21, 4/12/21 ER visit diagnosed Rhomboid Muscle strain. Rx methocarbamol and ibuprofen. Pain still occurring today 4/15/21.  4/13/21 chest pain and shortness of breath, ER visit diagnosed Esophageal Spasm. Rx extra Prevacid and mylanta. Symptoms still present today 4/15/21.
Received 2 shots one day apart; This case was reported by a pharmacist via call center representative and described the occurrence of extra dose administered in a adult male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Concomitant products included DIPHTHERIA VACCINE TOXOID + PERTUSSIS VACCINE ACELLULAR + TETANUS VACCINE TOXOID (BOOSTRIX).   On 26th October 2022, the patient received the 2nd dose of Boostrix. On 26th October 2022, unknown after receiving Boostrix, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.       Additional Information: GSK receipt date: 31-OCT-2022 Reporter's comment: The patient was around 40 years age. The pharmacist called to report that there was possible mistake with a patient and the Boostrix vaccine.  The pharmacist stated that the patient received a Boostrix vaccine and the next day of vaccination received another Boostrix shot by mistake.  The reporter consent to follow-up by email. Additional supportive information: The next day of vaccination, the patient received another Boostrix shot by mistake, which led to extra dose administered.
Soon after vaccine was administered, pt became fussy, continuous crying for 72 hours.  Quiets onlymomentarily and fever.
has seen 4 breakthrough cases of COVID 19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (has seen 4 breakthrough cases of COVID 19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (has seen 4 breakthrough cases of COVID 19). At the time of the report, COVID-19 (has seen 4 breakthrough cases of COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided by the reporter. Treatment medications were not provided by the reporter.
At 3:38 PM client was in mom's arm after receiving immunizations. Mom states child having difficulty breathing. Lips & surrounding area was cyanotic. Nurse called for another nurse & ER tray was brought in. 10 minutes later client was fine.
Pt. states that after receiving the 2nd dose of Phizer 04/19/2021, started experiencing symptoms 04/20/2021 of headaches (lasting 7 days), fatigue, and nausea. Pain in the joints of legs (hips & knees) right side worse. Primary visit treated (Injection of own Plasma). Symptoms have resolved.
HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A  expiry: UNKNOWN) dose was not reported, administered on 15-MAY-2021 for prophylactic vaccination. No concomitant medications were reported. On 15-MAY-2021, the subject experienced headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache. This report was non-serious.
INJECTED .8ML INSTEAD OF .5 ML OF THE JANSSEN COVID-19 VACCINE; This spontaneous report received from a health care professional concerned multiple patients (11 patients) of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 09-APR-2021, the subject experienced injected.8ml instead of.5 ml of the janssen covid-19 vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of injected .8ml instead of .5 ml of the janssen covid-19 vaccine was not reported. This report was non-serious.
Vaccine was administered in the shoulder joint instead of the deltoid muscle. Reaction is radiant heat, 2 inch diameter raised redness that is sensitive to the touch.
Dizziness; This is a spontaneous report from a contactable nurse (patient herself). A 43-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection; lot number: EL1283, expiration date was unknown), via an unspecified route of administration on the left arm on 08Jan2021 at 17:00 at a single dose for COVID-19 immunization. The patient received her first dose of bnt162b2, via an unspecified route of administration on the left arm on 19Dec2020 at 13:00. Both doses were administered at the hospital. The patient had no medical history. The patient had no known allergies; she had no allergies to medications, food, or other products. Concomitant medication included unspecified multivitamins. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the was not patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced dizziness on 10Jan2021 at 20:00, or 24 hours after the shot had been given. At the time of the report, at the 12 hour mark, she was still being dizzy. The reporter assessed the event as non-serious. The patient did not receive any treatment for the adverse event (AE). The patient was not recovered from the event.
awoke approx 2AM 20JUL93 w/cold sweat, states slept restlessly rest of noc; states felt cold, clammy, achy all day 20JUL; h/a & lt arm soreness all day treated w/ASA; swollen, reddened lt upper arm 20JUL;
Received three vaccines while in clinic. After the third vaccine, began to feel lightheaded.  No loss of consciousness. Dilated pupils, clammy and pale.  Vitals obtained, initial BP: 96/57, HR 39. Feet elevated and felt better after a few minutes.  Final vitals: BP- 116/66, HR 58. Refused further medical treatment and was escorted back to unit.
Patient started having fever at 8pm, he was shaking I took his temperature and it was 100.8. I gave him ADVIL, he went to sleep and woke up at 1 am shaking even more, with a temp. of 101.2. After 10 min he didn't respond to me, he couldn't talk, I took him to emergency, his fever reached 104 degrees, he was confused, he didn't know his name, where he was, he didn't know me. He recovered around 4.30am.
Felt achy all over, but especially in my hips, back and hands (where I fight arthritis). Also became very fatigued.
PT with history of previous syncopal events to both vaccinations and blood draw. 3 min after vaccine PT became unresponsive, arrived immediately at carside, supported airway, patient quickly regained consciousness. Vitals stable, refused transport.
Information has been received 12/3/02 via legal complaint from an attorney concerning a male pt who received series of Hib vaccines (manuf not stated), DTP vaccines (manuf not stated), and hep B (manuf not stated ) from August 1997 through October 1998 and experienced "the toxic neurological effects of mercury poisoning." Legal complaint also states that the pt experienced "mental and intellectual incapacity, developmental incapacity, learning disabilities, and affect disorders and impairments." The pt's symptoms resulted in persistent or significant disability/incapacity.
I have a headache across the lower backside of my head and my mind isn't clear. Also, I am unbalanced since I got out of bed this morning. It's hard to walk without swaying and sometimes stepping off the direction I'm going in.
7cmx7cm. Positive erythematous, positive tenderness, and positive warmth.
Pt fell alseep p/immun; Upon awaking 2.5 hrs later, had 2.5 hrs crying spell, very high pitched unconsolable, appeared very tense & scared; p/continual crying spell had many crying spells during day; no fever;
3-4 days after vaccination, pt developed bruising on her legs. over the next week, the bruising has continued. she currently has extensive bruised all over both legs. has 2 small faint bruises on L upper arm
Neck  tightness on left side  at 3:15 pm on 3/12/21 (30 min after vaccine) ice,, heat, and stretching Migraine with pain at base of neck up to sinus areas of face bilaterally, at 10:00 am on 3/14/21  until currently (4:30 pm 3/15/21) ice, heat, stretches, anti inflammatory, muscle relaxer, and cbd oil  medications, chiropractor  adjustment
Hypoesthesia in left arm & hand. Intermittent hypoesthesia in lips and jaw within 15 minutes of vaccination.  Dizziness and vision impairment after 35 minutes. I attempted to return to the store and fell over twice while walking there due to dizziness/blacking out.  Scraped my knees and chin.  Was helped by store employees, they checked my blood pressure and cleaned the wounds on my knees (from falling). Hypotension (88/50) upon returning to the store. Drank fluid, ate, was taken to urgent care. At urgent care, normal blood sugar (104),  still hypotensive (86/56) approximately 2 hours after vaccination but I felt less dizzy, no vision abnormalities since being helped at the store. Remained at urgent care for over 2 hours, blood pressure was 99/62 at release.  Prior to release hypoesthesia largely resolved and was left with only arm pain.
Narrative: COVID infection following COVID vaccine series 05/11/2020 COVID swab, result: not detected 05/12 CXR impression: No Acute cardiopulmonary abnormality 01/07, Pfizer, dose #1 (NON-FACILITY) 01/28, Pfizer, dose #2 (NON-FACILITY) 08/12 pt cc: cough, fatigue, fever, dyspnea, exposure: unknown 08/22 COVID swab, result: detected 08/22 pt admit to medicine cc: shortness of breath dx: COVID-19 Pneumonia LOS: 7 days 08/22 CXR impression: interval development of bilateral airspace opacities. 08/22 FIBRINOGEN result: 480 08/22 DDIMER result: 6.08 08/22 SARS-COV-2 Variant Sequencing result: pending 08/22 FERRITIN result: 369.8 08/23 https://portal.vaers.org/rsa/intranet/images4/2023/3/2601587P_138f238e-4870-401c-ab59-856a11c1a193.jpgFIBRINOGEN result: 391 08/23 ESR result: 33 08/23 DDIMER result: 5.89 08/24 FIBRINOGEN result: 391 08/24 DDIMER result: 3.52 08/27 ESR result: 5 08/28 FIBRINOGEN result: 179 08/28 DDIMER result: 2.20 08/28 ESR result: <1 08/29 FIBRINOGEN result: 156 08/29 DDIMER result: 1.82 08/29 ESR 1
Arm pain, fever feel on skin - 9 hrs - 2 days. Diarrhea 18 hrs later. Joint pain, fatigue next day.